World's Best Scientists 2026 revealed!
Olivier Benveniste

Olivier Benveniste

D-Index & Metrics

Immunology

D-Index
70
Citations
16050
World Ranking
2435
National Ranking
100

Olivier Benveniste publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Olivier Benveniste sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 388 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Olivier Benveniste D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Olivier Benveniste sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Olivier Benveniste is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine, with a particular focus on inflammatory myopathies and related disorders. Their research spans several subfields including epidemiology, rheumatology, molecular biology, neurology, and dermatology, reflecting a multidisciplinary approach to medical science.

The main topics covered in their work include:

  • Inflammatory Myopathies and Dermatomyositis
  • Eosinophilic Disorders and Syndromes
  • Muscle Physiology and Disorders
  • Skin Diseases and Diabetes
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 Clinical Research Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Benveniste's publication record includes numerous appearances in several notable journals. Frequent publication venues are:

  • La Revue de Médecine Interne
  • Neuromuscular Disorders
  • Lara D. Veeken
  • Annals of the Rheumatic Diseases
  • Autoimmunity Reviews

Recent significant papers authored or coauthored by Benveniste include:

  • Immune-mediated necrotizing myopathy: clinical features and pathogenesis, 2020, Nature Reviews Rheumatology
  • Different phenotypes in dermatomyositis associated with anti-MDA5 antibody, 2020, Neurology
  • Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis, 2023, Cancer Discovery
  • Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities, 2020, Autoimmunity Reviews
  • Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies, 2020, JCI Insight

The researcher frequently collaborates with several individuals, including:

  • Yves Allenbach
  • Sarah Léonard-Louis
  • Werner Stenzel
  • K. Mariampillai
  • A. Rigolet

Benveniste's scholarly contributions are primarily situated within medicine, with 344 publications in total and particular emphasis on epidemiological and rheumatological aspects.

Best Publications

  • Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.

    Sylvie Boutin;Virginie Monteilhet;Philippe Veron;Christian Leborgne

  • 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.

    Yves Allenbach;Andrew L Mammen;Olivier Benveniste;Werner Stenzel

  • Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

    Kubéraka Mariampillai;Benjamin Granger;Damien Amelin;Marguerite Guiguet

  • Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.

    Baptiste Hervier;Hervé Devilliers;Raluca Stanciu;Alain Meyer

  • Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

    Mehdi Touat;Thierry Maisonobe;Samuel Knauss;Omar Ben Hadj Salem

  • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

    Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel

  • Immune-mediated necrotizing myopathy: clinical features and pathogenesis.

    Yves Allenbach;Olivier Benveniste;Werner Stenzel;Olivier Boyer

  • High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

    Yves Allenbach;Jeremy Keraen;Anne-Marie Bouvier;Valérie Jooste

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Correlation of anti–signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

    Olivier Benveniste;Laurent Drouot;Fabienne Jouen;Jean-Luc Charuel

  • JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.

    Leandro Ladislau;Leandro Ladislau;Xavier Suárez-Calvet;Xavier Suárez-Calvet;Ségolène Toquet;Océane Landon-Cardinal

  • Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases

    Yves Allenbach;Yurdagul Uzunhan;Ségolène Toquet;Gaëlle Leroux

  • Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy.

    Norma B. Romero;Serge Braun;Olivier Benveniste

  • A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8

    Virginie Monteilhet;Samir Saheb;Sylvie Boutin;Christian Leborgne

  • Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

    Benjamin Terrier;Guillaume Geri;Wahiba Chaara;Yves Allenbach

  • Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients

    David Lebeaux;Camille Francès;Stéphane Barete;Bertrand Wechsler

  • Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution.

    Céline Anquetil;Joe-Elie Salem;Bénédicte Lebrun-Vignes;Douglas B. Johnson

  • Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups

    Simon Rothwell;Robert G Cooper;Ingrid E Lundberg;Frederick W Miller

  • Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

    Louiza Arouche-Delaperche;Yves Allenbach;Damien Amelin;Corinna Preusse

  • Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.

    Yves Allenbach;Louiza Arouche-Delaperche;Corinna Preusse;Helena Radbruch

  • Mechanisms Involved in the Low-Level Regeneration of CD4+ Cells in HIV-1—Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads

    Olivier Benveniste;Antoine Flahault;Florence Rollot;Carole Elbim

  • Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis

    Lénaig Mescam-Mancini;Yves Allenbach;Yves Allenbach;Baptiste Hervier;Baptiste Hervier;Hervé Devilliers

Frequent Co-Authors

Lucile Musset
Lucile Musset Sorbonne University
Bruno Eymard
Bruno Eymard Université Paris Cité
Olivier Boyer
Olivier Boyer University of Rouen
Patrice Cacoub
Patrice Cacoub Sorbonne University
David Klatzmann
David Klatzmann Sorbonne University
Eric Hachulla
Eric Hachulla University of Lille
David Saadoun
David Saadoun Université Paris Cité
Ingrid E. Lundberg
Ingrid E. Lundberg Karolinska University Hospital
Michael G. Hanna
Michael G. Hanna University College London
Nathalie Costedoat-Chalumeau
Nathalie Costedoat-Chalumeau Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology, exploring related healthcare degrees online can broaden career opportunities. Nursing programs, in particular, offer diverse paths that complement immunology knowledge.

Many students begin with which lpn programs are easiest to get into, providing a quicker entry into the healthcare field. These programs serve as stepping stones toward more advanced nursing roles.

For non-nurses aiming to change careers, several options exist like online rn programs for non nurses. These programs fast-track the pathway into registered nursing, leveraging prior experience or education from other fields.

To accelerate clinical expertise, students can consider easiest accelerated nursing programs that facilitate quicker BSN completion, allowing earlier entry into immunology-focused clinical roles.

Finally, for nurses ready to take on advanced responsibilities, accelerated rn to np programs prepare candidates for nurse practitioner roles, often specializing in immunology-related care such as infectious diseases or autoimmune conditions.

Exploring these related degrees supports a well-rounded approach to immunology careers, combining scientific understanding with practical healthcare skills.

Best Scientists Citing Olivier Benveniste

Trending Scientists

Recently Published Articles